Vitamin B Derivative (Nicotinamide)Appears to Reduce Skin Cancer Risk.
Vitamin B Derivative (Nicotinamide)Appears to Reduce Skin Cancer Risk.
Skin Therapy Lett. 2017 Sep;22(5):1-4
Authors: Nazarali S, Kuzel P
Abstract
Nicotinamide, an amide form of vitamin B3, has shown the potential to treat a variety of dermatological conditions, including acne, rosacea, and atopic dermatitis. Recent studies have demonstrated the role of nicotinamide, in both topical and oral forms, as a chemopreventive agent against skin cancer. Its anti-carcinogenic role may be due to its ability to enhance DNA repair and prevent ultraviolet (UV)-induced immunosuppression, which is known to contribute to the progression of pre-malignant lesions. Furthermore, nicotinamide is a precursor of essential coenzymes for many important reactions in the body, including the production of nicotinamide adenine dinucleotide (NAD). NAD is a key coenzyme in the synthesis of adenosine triphosphate (ATP), which transports chemical energy within cells. Therefore, nicotinamide plays a significant role in supporting energy-dependent cellular processes, including DNA repair.
PMID: 28888216 [PubMed - in process]
Source: Skin Therapy Letter - Category: Dermatology Authors: Nazarali S, Kuzel P Tags: Skin Therapy Lett Source Type: research
More News: Acne | Cancer | Cancer & Oncology | Chemistry | Dermatitis | Dermatology | Gastroschisis Repair | Oral Cancer | Rosacea | Skin | Skin Cancer | Study | Vitamin B | Vitamin B3 | Vitamins